Applied Genetic Technologies Corporation
AGTC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | 100% | – | – |
| R&D Expenses | $13 | $14 | $9 | $14 |
| G&A Expenses | $4 | $4 | $4 | $4 |
| SG&A Expenses | $4 | $4 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $17 | $18 | $14 | $18 |
| Operating Income | -$0 | -$18 | -$14 | -$20 |
| % Margin | – | -5,453.2% | – | – |
| Other Income/Exp. Net | $18 | -$2 | -$1 | -$1 |
| Pre-Tax Income | $0 | -$18 | -$14 | -$19 |
| Tax Expense | -$17 | $1 | $1 | -$1 |
| Net Income | $17 | -$19 | -$15 | -$18 |
| % Margin | – | -5,837.5% | – | – |
| EPS | 0.26 | -0.42 | -0.34 | -0.43 |
| % Growth | 161.9% | -23.5% | 20.9% | – |
| EPS Diluted | 0.38 | -0.42 | -0.34 | -0.43 |
| Weighted Avg Shares Out | 45 | 45 | 44 | 43 |
| Weighted Avg Shares Out Dil | 45 | 45 | 44 | 43 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$1 | $1 | $1 | -$1 |
| Depreciation & Amortization | -$17 | $0 | $0 | $1 |
| EBITDA | -$17 | -$17 | -$13 | -$18 |
| % Margin | – | -5,335.7% | – | – |